The gemfibrozil cost-benefit model
Subtitle: analysis of data from the Helsinki Heart Study, model development, and extension to the California Medicaid population
By: Syam Sarma.
Contributors: Rand Graduate School.
Series: Dissertation; Dissertation (Rand Graduate School)
Publisher: RAND
Published: 1993
Place of publication: Santa Monica, CA (1700 Main St., P.O. Box 2138, Santa Monica 90407-2138)
Language: eng
Number of pages: 139
Subjects: Cost-Benefit Analysis -- economics -- United States -- statistics.; Gemfibrozil -- therapeutic use.; Hyperlipidemia -- drug therapy.; Coronary Disease -- economics -- United States -- statistics.; Medicaid -- economics -- California -- statistics.; Coronary heart disease -- Treatment.; Coronary heart disease -- Prevention -- Finland.; Digoxin.; Medicaid -- California.
Notes: "RAND Graduate School."

"RSGD-105."

Includes bibliographical references (p. 127-139).